Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Vomiting 9Nausea 5Breast Neoplasms 4Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Myeloproliferative Disorders 1Multiple Myeloma 1Leukemia, Myeloid, Acute 1Inflammatory Breast Neoplasms 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1

Interventions

Cyclophosphamide 10Radiotherapy 6Epirubicin 6Paclitaxel 5Docetaxel 5Trastuzumab 4Fluorouracil 4Doxorubicin 4Tamoxifen 3Neoadjuvant Therapy 3pertuzumab 2Surgical Procedures, Operative 2Filgrastim 2ferric carboxymaltose 1Thiotepa 1Taxes 1Razoxane 1Radiation 1Prochlorperazine 1Peripheral Blood Stem Cell Transplantation 1Palonosetron 1Microarray Analysis 1Methotrexate 1Injections, Subcutaneous 1Immunohistochemistry 1Granulocyte Colony-Stimulating Factor 1Granisetron 1Dexrazoxane 1Dexamethasone 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Inflammatory Breast Neoplasms × Aprepitant × Clear all
NCT00475085 2015-11-10

Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial

University of Rochester

Phase 3 Completed
1,021 enrolled 10 charts
Breast

Breast Neoplasms, Nausea, Vomiting, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡